NIH-funded research R01 grant

Exploring how unrealistic optimism affects opioid use and relapse

Official title: Computational psychiatry investigation of the role of unrealistic optimism in opioid use disorder and relapse

Funded at Rutgers Biomedical and Health Sciences · NIH-11005768 · Data updated 2026-11-12

This study is looking at how being overly optimistic might affect people with opioid use disorder and their chances of relapsing, so we can better understand their decision-making and help create more effective treatment plans.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startMarch 1, 2021
Project endDecember 31, 2025
Funding year2025
Award (this year)$537,137
NIH project number5R01DA053282-05
Project IDNIH-11005768 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with opioid use disorder who are currently engaged in treatment.

Less likely to help

Patients who are not currently undergoing treatment for opioid use disorder may not benefit from this research.

What this research studies

This research investigates the role of unrealistic optimism in patients with opioid use disorder (OUD) and how it may contribute to relapse. By utilizing advanced neurocognitive tools and a longitudinal design, the study aims to understand the decision-making processes that lead to opioid reuse. Patients will undergo assessments that measure their tolerance for uncertainty and optimism bias while participating in tasks that simulate real-life decision-making scenarios. The findings could help identify patients at higher risk for relapse and inform more effective treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved interventions that reduce the risk of relapse in individuals with opioid use disorder.

How similar studies have gone: Previous research has shown promising results in understanding decision-making processes in addiction, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Konova, Anna Borisova — Rutgers Biomedical and Health Sciences
  • Study coordinator: Konova, Anna Borisova

Related research

Other NIH-funded projects on the same topics.

  • Real-time relapse risk scoring for Opioid Use Disorder from trial data

    A tool that uses data from opioid treatment trials to produce a real-time score predicting a patient’s risk of relapse in the near future.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-11374999

  • Smartphone app helps people on opioid treatment stay abstinent

    A smartphone app called OPTiMA supports people on medication-assisted treatment to stay in recovery by daily self-checks and personalized feedback.

    NIH research Univ of Arkansas for Med Scis · Little Rock, United States · NIH-11332430

  • Predicting Relapse Risk for Opioid Use Disorder

    This project is creating a tool to help doctors understand a patient's risk of relapse for Opioid Use Disorder in real-time, using information from past treatment.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-11113878

  • Predicting relapse risk for patients with Opioid Use Disorder

    This study is working on a new tool that helps doctors predict the chances of someone with Opioid Use Disorder relapsing, using information like their treatment habits and drug tests, so they can provide better support when it's needed most.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-10892020

  • Combining buprenorphine with extended-release naltrexone to prevent opioid relapse

    This project checks whether adding daily buprenorphine to monthly extended‑release naltrexone helps people with opioid use disorder stay off opioids.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-10861050

  • Using smartphone apps to help prevent relapse in people with opioid use disorder

    This study is testing a smartphone app called OPTiMA to see if it can help people with opioid use disorder stay on track and avoid relapse, by giving them daily check-ins and personalized tips, while comparing it to a group that only gets regular monitoring.

    NIH research Univ of Arkansas for Med Scis · Little Rock, United States · NIH-10844489

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.